File:PMC5412888 JDE-44-355-g003.png
PMC5412888_JDE-44-355-g003.png (512 × 411 pixels, file size: 481 KB, MIME type: image/png)
License
Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)
Summary
Author:Hidehisa Saeki, Hidemi Nakagawa, Ko Nakajo,Taeko Ishii, Yoji Morisaki, Takehiro Aoki, Gregory S. Cameron, Olawale O. Osuntokun,Department of Dermatology, Nippon Medical School,Department of Dermatology, The Jikei University School of Medicine, Lilly Research Laboratories, Eli Lilly Japan K.K.,Lilly Research Laboratories, Eli Lilly and Company (Openi/National Library of Medicine) Source:https://openi.nlm.nih.gov/detailedresult?img=PMC5412888_JDE-44-355-g003&query=Ixekizumab&it=xg&req=4&npos=1 Description:jde13622-fig-0003: Representative photographs of a patient with erythrodermic psoriasis taken at baseline (week 0)6 and after 52 weeks of treatment with ixekizumab. PASI, Psoriasis Area and Severity Index.
File history
Click on a date/time to view the file as it appeared at that time.
| Date/Time | Thumbnail | Dimensions | User | Comment | |
|---|---|---|---|---|---|
| current | 21:37, 30 October 2021 | | 512 × 411 (481 KB) | Ozzie10aaaa (talk | contribs) | Author:Hidehisa Saeki, Hidemi Nakagawa, Ko Nakajo,Taeko Ishii, Yoji Morisaki, Takehiro Aoki, Gregory S. Cameron, Olawale O. Osuntokun,Department of Dermatology, Nippon Medical School,Department of Dermatology, The Jikei University School of Medicine, Lilly Research Laboratories, Eli Lilly Japan K.K.,Lilly Research Laboratories, Eli Lilly and Company (Openi/National Library of Medicine) Source:https://openi.nlm.nih.gov/detailedresult?img=PMC5412888_JDE-44-355-g003&query=Ixekizumab&it=xg&req=4... |
You cannot overwrite this file.
File usage
There are no pages that use this file.
